טוען...
Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer
BACKGROUND/AIM: We have previously found elevated levels of endoglin (CD105) in the prostate cancer (PC) tissue of men with poor prognosis, compared to men with indolent disease. Herein, we examined whether plasma levels of the soluble form of CD105 (sCD105) differ according to the PC grade at diagn...
שמור ב:
| הוצא לאור ב: | Anticancer Res |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768804/ https://ncbi.nlm.nih.gov/pubmed/32132043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/anticanres.14088 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|